Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gerd Zettlmeissl Insider Profile
4 Followers
Gerd Zettlmeissl, Director at Medigene, holds ― shares in Medigene (Ticker: GB:0QGJ). Most recently, Gerd Zettlmeissl Bought €10,000 shares of Medigene on May 15, 2024 for an estimated value of 12.00K.
Gerd Zettlmeissl has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Gerd Zettlmeissl does not currently own shares as a corporate insider.
A breakdown of Gerd Zettlmeissl's holdings
Insider Roles
Director
Roles that Gerd Zettlmeissl holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Gerd Zettlmeissl
Gerd Zettlmeissl's Trading History
List of latest transactions for each holding click on a transaction to see Gerd Zettlmeissl's performance on stock
You May Also Like
Gerd Zettlmeissl insider profile FAQ
What is the percentage of profitable transactions made by Gerd Zettlmeissl?
The percentage of profitable transactions made by Gerd Zettlmeissl is ―.
What is the average return per transaction made by Gerd Zettlmeissl?
The average return per transaction made by Gerd Zettlmeissl is ―.
What stocks does Gerd Zettlmeissl hold?
Gerd Zettlmeissl holds: GB:0QGJ stocks.
What was Gerd Zettlmeissl’s latest transaction?
Gerd Zettlmeissl latest transaction was an Informative Buy of €12.00K.
What was Gerd Zettlmeissl's most profitable transaction?
Gerd Zettlmeissl’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Gerd Zettlmeissl's role in Medigene?
Gerd Zettlmeissl's role in Medigene is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.